These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22067768)

  • 1. A life-threatening ectopic pregnancy with etonogestrel implant.
    Bouquier J; Fulda V; Bats AS; Lécuru F; Huchon C
    Contraception; 2012 Feb; 85(2):215-7. PubMed ID: 22067768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ectopic pregnancy with etonogestrel contraceptive implant (Implanon): first case].
    Mansour M; Louis-Sylvestre C; Paniel BJ
    J Gynecol Obstet Biol Reprod (Paris); 2005 Oct; 34(6):608-9. PubMed ID: 16208205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etonogestrel implant (Implanon) for contraception.
    Drug Ther Bull; 2001 Aug; 39(8):57-9. PubMed ID: 11526801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathy associated with etonogestrel implant insertion.
    Brown M; Britton J
    Contraception; 2012 Nov; 86(5):591-3. PubMed ID: 22770789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectopic pregnancy with Implanon® as a method of contraception in a woman with a previous ectopic pregnancy - case report.
    Olowu O; Karunaratne J; Odejinmi F
    Eur J Contracept Reprod Health Care; 2011 Jun; 16(3):229-31. PubMed ID: 21332385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pregnancy with Implanon: a report on three cases].
    Boucoiran I; Trastour C; Faraj L; Delotte J; Bongain A
    Gynecol Obstet Fertil; 2011 Feb; 39(2):e52-4. PubMed ID: 21288755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience.
    Graesslin O; Korver T
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():4-12. PubMed ID: 18330813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability and clinical safety of Implanon.
    Blumenthal PD; Gemzell-Danielsson K; Marintcheva-Petrova M
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():29-36. PubMed ID: 18330815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding related to etonogestrel subdermal implant in a US population.
    Casey PM; Long ME; Marnach ML; Bury JE
    Contraception; 2011 May; 83(5):426-30. PubMed ID: 21477684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-abortion contraception with etonogestrel subdermal implant.
    Barros Pereira I; Carvalho RM; Graça LM
    Eur J Obstet Gynecol Reprod Biol; 2015 Feb; 185():33-5. PubMed ID: 25522115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.
    Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E;
    Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital.
    Aisien AO; Enosolease ME
    Niger J Clin Pract; 2010 Sep; 13(3):331-5. PubMed ID: 20857796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implanon® failure in an HIV-positive woman on antiretroviral therapy resulting in two ectopic pregnancies.
    McCarty EJ; Keane H; Quinn K; Quah S
    Int J STD AIDS; 2011 Jul; 22(7):413-4. PubMed ID: 21729965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the subdermal contraceptive etonogestrel implant (Implanon) on biochemical and hormonal parameters (three years follow-up).
    Inal MM; Yildirim Y; Ertopcu K; Avci ME; Ozelmas I; Tinar S
    Eur J Contracept Reprod Health Care; 2008 Sep; 13(3):238-42. PubMed ID: 18609340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon.
    Wenzl R; van Beek A; Schnabel P; Huber J
    Contraception; 1998 Nov; 58(5):283-8. PubMed ID: 9883383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant.
    Bennink HJ
    Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():12-20. PubMed ID: 11246602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life of women using the etonogestrel long-acting reversible contraceptive implant after abortion for unplanned pregnancy.
    Caruso S; Vitale SG; Fava V; Pasqua SD; Rapisarda AMC; Cianci S
    Eur J Contracept Reprod Health Care; 2020 Aug; 25(4):251-258. PubMed ID: 32436733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for removal of etonogestrel implant within two years of use in Jos, Nigeria.
    Mutihir JT; Nyango DD
    East Afr Med J; 2010 Nov; 87(11):461-4. PubMed ID: 23457809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users.
    Lazorwitz A; Davis A; Swartz M; Guiahi M
    Contraception; 2017 Jun; 95(6):571-577. PubMed ID: 28288788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implanon. The new alternative.
    Cherry S
    Aust Fam Physician; 2002 Oct; 31(10):897-900. PubMed ID: 12404826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.